1. Home
  2. PFX vs STIM Comparison

PFX vs STIM Comparison

Compare PFX & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFX

PhenixFIN Corporation

N/A

Current Price

$44.56

Market Cap

89.7M

Sector

Finance

ML Signal

N/A

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$2.11

Market Cap

105.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFX
STIM
Founded
2010
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.7M
105.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
PFX
STIM
Price
$44.56
$2.11
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
1.5K
1.4M
Earning Date
02-06-2026
03-03-2026
Dividend Yield
3.36%
N/A
EPS Growth
N/A
N/A
EPS
2.06
N/A
Revenue
$25,262,322.00
$129,873,000.00
Revenue This Year
N/A
$101.67
Revenue Next Year
N/A
$10.87
P/E Ratio
$20.61
N/A
Revenue Growth
13.89
78.61
52 Week Low
$41.00
$1.25
52 Week High
$57.40
$5.92

Technical Indicators

Market Signals
Indicator
PFX
STIM
Relative Strength Index (RSI) 53.15 61.96
Support Level $42.88 $2.05
Resistance Level $43.75 $2.29
Average True Range (ATR) 0.66 0.20
MACD -0.06 0.04
Stochastic Oscillator 53.78 70.94

Price Performance

Historical Comparison
PFX
STIM

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: